New scan aims to sharpen breast cancer detection
NCT ID NCT05634954
Summary
This early-stage study aimed to test a new radioactive tracer for PET scans, called [18F]GEH121224, to see if it could better detect and monitor HER2-positive breast cancer that has spread. The study planned to enroll 12 women with advanced breast cancer to check the safety of the tracer, measure how much radiation the body absorbs from it, and find the best time to take the scan images. The trial was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Texas MD Anderson Cancer Centre
Houston, Texas, 77030-4008, United States
Conditions
Explore the condition pages connected to this study.